Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.  Adeniran EA, Quinn M, Liu Y, Brooks B, Pack RP. Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare…

Characteristics of accountable care organizations offering methadone to patients with opioid use disorder.  Crawford M, Barsky BA, Huskamp HA, Brunette MF, Meara E.  Health Aff Sch. 2025 Apr 9;3(4):qxaf074. doi: 10.1093/haschl/qxaf074. P…

Filling the Treatment Gap: Geographic Expansion of Buprenorphine Providers Across the U.S.  Das S, Muhetaer K, Gandotra N, Tomoyasu N.  AJPM Focus. 2024 Oct 16;4(1):100284. doi: 10.1016/j.focus.2024.100284. PMID: 40225958; PMCID: PMC1199…

Barriers and facilitators to prescribing buprenorphine for treating opioid use disorder among emergency department and other practice setting physicians.  Swartz JA, Franceschini D, Marino NM, Call AH, Rosenberger L, Whitehouse S.  AIMS…

Inequities in Opioid Administration by Race and Ethnicity for Hospitalized Patients With and Without Substance Use Disorders.  Rambachan A, Fang MC.  J Gen Intern Med. 2025 Apr 25. doi: 10.1007/s11606-025-09514-6. Epub ahead of print. PM…

Outcome of Buprenorphine maintenance treatment among Indian females with opioid dependence: Report from a tertiary addiction treatment center.  Mandal P, Ambekar A, Choudhary H, Bagri S.  Indian J Psychiatry. 2025 Mar;67(3):303-309. doi…